Yisheng Biopharma sets up new divisions in Southeast Asia

| By | Cancer Drugs, Drug Development, R&D
0
106

Yisheng Biopharma, a biopharmaceutical company focusing on research, development, manufacturing, sales and marketing of immunological biologics and vaccines, announced the opening of Anderson Biotech Company Limited and Royal OncoCare Hospitality as two wholly owned subsidiaries of Yisheng Biopharma in Cambodia.

Yivyka is an innovative immuno-oncology drug recently granted a drug registration license by the Ministry of Health of the Kingdom of Cambodia. Yivyka is the first biological product introduced into the Cambodia market by Yisheng Biopharma.

Yisheng Biopharma was founded in 2002 and is based in Beijing (China). The company is focused on discovering, developing and commercializing innovative immunological biologics. With approximately 700 employees worldwide and operations in China, the United States, Singapore and certain Southeast Asian countries.

SOURCE: prnewswire
SHARE
GMP news
Pharmaceutical industry News and events. Technology transfer and contract manufacturing of medicines.